Federal Circuit Reviews Sandoz Appeal to Overturn $39 Million Patent Verdict ضد Allergan

The Federal Circuit is currently examining an appeal by Sandoz concerning a $39 million patent infringement verdict linked to Allergan’s eyelash growth product. A significant point of contention involves one judge’s skepticism about Sandoz’s reliance on a precedent from a decade-old case involving a similar patent, which they argue renders the current case invalid. This legal battle represents Sandoz’s effort to overturn the hefty financial penalty imposed on them. For more detailed analysis, visit Law360.